Intrauterine devices (IUDs) are long-acting contraceptive methods widely used in contemporary clinical practice, standing out for their high efficacy, safety, reversibility, and favorable cost-effectiveness. This article aimed to conduct an integrated analysis of the main aspects related to the use of IUDs, addressing insertion techniques, clinical limitations, adverse impacts, and clinical and social benefits. Initially, general concepts and the different types of devices available are discussed, emphasizing their mechanisms of action and eligibility criteria, which allow the indication of the method for diverse profiles of women, including nulliparous women, adolescents, and postpartum women. Subsequently, the steps of the insertion technique and the care required before and after the procedure are described, highlighting the importance of continuous clinical follow-up. The study also addresses the limitations associated with IUD use, such as access barriers, adaptation difficulties, and the influence of sociocultural factors, as well as the most frequently observed adverse impacts, including changes in menstrual patterns, pelvic pain, risk of infection, device expulsion, and, rarely, uterine perforation. In addition, the benefits of IUDs are highlighted, such as their high contraceptive efficacy, the reproductive autonomy provided to women, ease of use, and positive impact on reducing unplanned pregnancies. Finally, the article emphasizes the fundamental role of Primary Health Care in expanding access to the method and promoting reproductive rights, reinforcing that the appropriate use of IUDs significantly contributes to the improvement of reproductive health indicators and the strengthening of public policies aimed at family planning.

Monkeypox (MPOX), é uma zoonose viral transmitida pelo contato com material corporal contaminado. O quadro clínico costuma apresentar sintomas leves a moderados, como febre, mialgia, fadiga, cefaleia, astenia, dor nas costas e linfadenopatia, sendo as lesões de pele, sinais muito característicos da doença e essenciais para a identificação dos casos e exclusão de diagnósticos diferenciais. Os casos suspeitos/prováveis/confirmados devem ser imediatamente notificados, isolados e tratados, sendo que, atualmente não há tratamento específico para a doença, sendo adotada a conduta de sintomáticos. O Brasil registrou 50.029 notificações, destas, 10.247 confirmadas, 332 prováveis, 3.548 suspeitos e 35.902 descartados, perda de seguimento e exclusões até o 19º Boletim epidemiológico. O presente trabalho buscou organizar as principais informações da moléstia, por meio de uma revisão integrativa com o objetivo de elucidar de maneira clara e atualizada a história natural da doença e destacar os dados epidemiológicos no Brasil e na cidade de São José dos Campos, São Paulo.

Seborrheic dermatitis is a chronic inflammatory skin disorder that predominantly affects areas rich in sebaceous glands, including the scalp, face, and upper trunk. Although not life-threatening, it significantly impacts quality of life due to persistent erythema, pruritus, and visible scaling. Its etiology is multifactorial, involving complex interactions among sebaceous gland activity, Malassezia yeast proliferation, immune dysregulation, genetic susceptibility, and external triggers such as stress and climate changes. These factors create a permissive environment for inflammation, leading to recurrent flare-ups and chronic disease patterns. Clinically, seborrheic dermatitis presents with greasy scales, erythematous patches, and variable pruritus, with manifestations ranging from mild dandruff to severe, widespread involvement. Differential diagnosis is essential, especially in distinguishing the condition from psoriasis, atopic dermatitis, and infectious dermatoses. Diagnosis is primarily clinical but may be aided by dermoscopy or laboratory testing in atypical cases. Treatment includes topical antifungals, corticosteroids, calcineurin inhibitors, keratolytic agents, and specific medicated shampoos. Systemic therapies may be required for refractory cases, while maintenance regimens are crucial to reduce relapse frequency. Emerging research highlights the importance of the cutaneous microbiome and genetic factors, suggesting future opportunities for personalized therapeutic approaches. Comprehensive patient education and long-term management strategies remain essential components of effective care.